Article
Prognostic value of TERT promoter mutations in conjunctival melanomas in addition to clinicopathological features.
The British journal of ophthalmology - 1 Oct 2021
van Ipenburg J A, Naus N C, Dubbink H J, van Ginderdeuren R, Missotten G S, Paridaens D, Verdijk R M
Abstract excerpt
AIMS: To evaluate the prognostic value of clinical, histopathological and molecular features and to relate different treatment modalities to clinical outcome in conjunctival melanomas (CM). METHODS: Retrospective review of clinical, histopathological and BRAF V600E and telomerase reverse transcriptase (TERT) promoter mutation status and treatment modalities, correlated to recurrence and metastasis in 79 patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
